Vol 10, No 2 (2018)

Mol Cell Pharmacol

Table of Contents

FDA Corner

FDA Approves Novel Preventive Treatment for Migraine Abstract PDF
FDA Approves First Drug Comprised of an Active Ingredient Derived From Marijuana to Treat Rare, Severe Forms of Epilepsy Abstract PDF
FDA Approves First-of-its Kind Targeted RNA-based Therapy to Treat a Rare Disease Abstract PDF

LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 

Copyright © 2008 LumiText Publishing. All rights reserved.